Latest filing published 03 Dec 2020 for Silence Therapeutics plc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Steven Romano: trading record in brief
This profile gathers the share dealings of Steven Romano in Silence Therapeutics plc. We count 2 filings; the first trade dates from 2 October 2019 and the latest from 30 November 2020.
No open-market sale appears; the market trades are 2 purchases worth €22k. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2020: 1 purchase and no sales on the market.
The latest filing, published on 3 December 2020, reports an open-market purchase in Silence Therapeutics plc. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Steven Romano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,500 sharesOutside a trading venueISIN GB00B9GTXM62FCA-NSM:3802673Canonical exit: 28 Feb 2021 (T+90)
- 10,000 shares@ £1.93100.0% of flowLondon Stock Exchange, AIMISIN GB00B9GTXM62FCA-NSM:LSE20191002170914_14251761_20200326185156245_34505Canonical exit: 31 Dec 2019 (T+90)
2 of 2 declarations